| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996511 | Practical Radiation Oncology | 2016 | 7 Pages |
Abstract
ENI significantly reduces the risk of cervical nodal recurrence in ENB patients with clinically N0 neck, but this did not translate to a survival benefit. Multimodality treatment for isolated neck recurrence provides a reasonable salvage rate. The greatest benefit for ENI appeared to be among younger patients who presented with Kadish C disease. Further studies are needed to confirm these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Wen MD, PhD, Abdallah S.R. MD, MSc, Clifton David MD, PhD, Betty Y.S. MD, PhD, Chad MD, G. Brandon MD, Ehab Y. MD, Steven J. MD, Shirley Y. MD, Eduardo MD, Michael E. MD, Beth M. MD, PhD, William H. MD, Heath MD, PhD, Stephen Y. MD, PhD, Adel K. MD,